HomeFUNDING

FUNDING

Otolith Labs Announces Closing of $3.3 Million in Seed Financing; Receives “Breakthrough Device” Designation from FDA for Its Prescription Treatment for Vertigo

Investors include Mark Cuban; founders of three companies acquired by large strategics; and four leading ENTs.

Bioretec Completes 7.2 M€ Equity Funding Round

The company focuses to the registration and commercialization of RemeOs™ trauma screws.

NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions

To date, NuvoAir has partnered with providers across the U.S., U.K. and Europe, including Harvard Boston Children's Hospital, New Hampshire's Dartmouth-Hitchcock Medical Center, Royal Brompton Hospital, King's College Hospital in London, as well as pharmaceutical giants Roche, Regeneron and Novartis.

Trudell Medical Group Makes a Strategic Investment in Xenocor

In addition, George Baran, Chair of the Trudell Medical Group will join the Xenocor board.

Veranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization Medtech Services Company

As the first phase in building this global entity, Veranex has acquired three complementary solution providers: Ximedica, Quartesian, and Boston Healthcare Associates. By bringing these companies together, Veranex combines the industry’s key pillars of design and engineering, regulatory, clinical, and market access into a single-source solution.

BASMA.com Raises a $3M Series A Round to Scale Up Its Health Tech Platform in the MENA

The UK-based, MENA focused, startup BASMA.com closed $3M in its Series A round of funding led by MEVP with the participation of SOSF, IM capital and returning investors iSME, Cedar Mundi Ventures and IFA capital.

Garwood Medical Devices Concludes its Third Round of Funding (Raised an Additional $4M)

Garwood Medical has now raised $11.4 million, including $3.8 million in the Series B round, which closed October 2019 and was over-subscribed by $800,000. The company raised an initial $3.6 million during the company's Series A financing round, which closed in September 2016. Funds raised will continue to support pre-clinical testing.

FineHeart Raises €15 million Series B Funding

The First In Human implantation of the ICOMS FLOWMAKER® is assured following this financing.

Myra Vision, A Shifamed Portfolio Company, Closes $17M In Series A Financings

The financings were led by The Capital Partnership, with participation from Cormorant Asset Management and Shifamed angel investors. In conjunction with the financing, the company has changed its name to Myra Vision, Inc. from Myra Medical, Inc.